| Stephanie Elizabeth Pollard, MD, MPH | |
|
6565 N Charles St Ste 406, Baltimore, MD 21204-5803 | |
| (216) 778-4486 | |
| Not Available |
| Full Name | Stephanie Elizabeth Pollard |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 8 Years |
| Location | 6565 N Charles St Ste 406, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609230317 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | D89503 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Greater Baltimore Medical Center | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Greater Baltimore Medical Center Inc | 1759276975 | 309 |
News Archive
The University of Missouri-Kansas City has received a $400,000 gift to establish a pulmonary fibrosis research program at the UMKC School of Medicine. The gift comes from the estate of the late Mary K. Geldmacher, a retired St. Louis school teacher who suffered from pulmonary fibrosis and passed away in 2009. Pulmonary fibrosis is the formation or development of excess fibrous connective tissue in the lungs, commonly described as "scarring of the lung."
Researchers from the National Institute of Standards and Technology (NIST) and University of Colorado Boulder (CU) have developed a low-power microchip that uses a combination of microfluidics and magnetic switches to trap and transport magnetic beads. The novel transport chip may have applications in biotechnology and medical diagnostics.
A secondary analysis of two large clinical trials fails to settle the question of whether use of the bispectral index rather than end-tidal anesthetic concentration to monitor general anesthesia results in faster patient recovery.
The Utah Health Information Network (UHIN) today announced a new pilot program to connect rural health care providers in the Moab, Utah region with the Department of Veteran Affairs (VA) to improve access and coordination of patient care for veterans and service members living in rural areas.
Differences in growth factor (GF) signaling may cause the poor prognosis in some breast cancer cases. A new study, published in the open access journal BMC Medical Genomics, suggests that some estrogen receptor-positive breast cancers respond poorly to tamoxifen because of increased GF signaling.
› Verified 8 days ago
| Entity Name | Greater Baltimore Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891855763 PECOS PAC ID: 1759276975 Enrollment ID: O20040217000852 |
News Archive
The University of Missouri-Kansas City has received a $400,000 gift to establish a pulmonary fibrosis research program at the UMKC School of Medicine. The gift comes from the estate of the late Mary K. Geldmacher, a retired St. Louis school teacher who suffered from pulmonary fibrosis and passed away in 2009. Pulmonary fibrosis is the formation or development of excess fibrous connective tissue in the lungs, commonly described as "scarring of the lung."
Researchers from the National Institute of Standards and Technology (NIST) and University of Colorado Boulder (CU) have developed a low-power microchip that uses a combination of microfluidics and magnetic switches to trap and transport magnetic beads. The novel transport chip may have applications in biotechnology and medical diagnostics.
A secondary analysis of two large clinical trials fails to settle the question of whether use of the bispectral index rather than end-tidal anesthetic concentration to monitor general anesthesia results in faster patient recovery.
The Utah Health Information Network (UHIN) today announced a new pilot program to connect rural health care providers in the Moab, Utah region with the Department of Veteran Affairs (VA) to improve access and coordination of patient care for veterans and service members living in rural areas.
Differences in growth factor (GF) signaling may cause the poor prognosis in some breast cancer cases. A new study, published in the open access journal BMC Medical Genomics, suggests that some estrogen receptor-positive breast cancers respond poorly to tamoxifen because of increased GF signaling.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Elizabeth Pollard, MD, MPH 130 Lighthouse Dr, Jupiter, FL 33469-3511 Ph: () - | Stephanie Elizabeth Pollard, MD, MPH 6565 N Charles St Ste 406, Baltimore, MD 21204-5803 Ph: (216) 778-4486 |
News Archive
The University of Missouri-Kansas City has received a $400,000 gift to establish a pulmonary fibrosis research program at the UMKC School of Medicine. The gift comes from the estate of the late Mary K. Geldmacher, a retired St. Louis school teacher who suffered from pulmonary fibrosis and passed away in 2009. Pulmonary fibrosis is the formation or development of excess fibrous connective tissue in the lungs, commonly described as "scarring of the lung."
Researchers from the National Institute of Standards and Technology (NIST) and University of Colorado Boulder (CU) have developed a low-power microchip that uses a combination of microfluidics and magnetic switches to trap and transport magnetic beads. The novel transport chip may have applications in biotechnology and medical diagnostics.
A secondary analysis of two large clinical trials fails to settle the question of whether use of the bispectral index rather than end-tidal anesthetic concentration to monitor general anesthesia results in faster patient recovery.
The Utah Health Information Network (UHIN) today announced a new pilot program to connect rural health care providers in the Moab, Utah region with the Department of Veteran Affairs (VA) to improve access and coordination of patient care for veterans and service members living in rural areas.
Differences in growth factor (GF) signaling may cause the poor prognosis in some breast cancer cases. A new study, published in the open access journal BMC Medical Genomics, suggests that some estrogen receptor-positive breast cancers respond poorly to tamoxifen because of increased GF signaling.
› Verified 8 days ago
Miss Elizabeth Unique Morris, MSN, WHNP-BC Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 330 N Howard St, Baltimore, MD 21201 Phone: 410-576-1414 | |
Christine E. O Connor, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 227 Saint Paul St, 6th Floor, Baltimore, MD 21202 Phone: 410-332-9002 Fax: 410-783-5880 | |
Amara Chinyere Unegbu-ogbonna, PA-C Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 345 St. Paul Place, Bunting Building - Department Of Ob/gyn, Baltimore, MD 21202 Phone: 410-332-9000 | |
Fateh Hraky Sr., Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3001 S Hanover St, Suite 301, Baltimore, MD 21225 Phone: 410-350-0800 | |
Joyce A Bonsu, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3449 Wilkens Ave Ste 305, Baltimore, MD 21229 Phone: 410-644-2582 Fax: 410-644-6232 | |
Fouad M Abbas, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2411 W Belvedere Ave, Suite 206, Baltimore, MD 21215 Phone: 410-601-9030 | |
Dr. Ginny M Merryman, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6569 N Charles St, Suite 501, Baltimore, MD 21204 Phone: 410-938-8960 Fax: 410-583-9770 |